Roflumilast, ursodeoxycholic acid and nucleinate efficiency in patients with chronic obstructive pulmonary disease with accompanying chronic non-stone cholecystitis.
Global Initiative for diagnosis, treatment and prevention of COPD has recently included roflumilast (R) - an inhibitor of phosphodiesterase-4 (PDE-4) as a new therapeutic agent to the recommendations for the management of patients suffering from COPD with severe and moderate course. Objective. To in...
| Main Authors: | , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
SE "Dnipropetrovsk medical academy of Health Ministry of Ukraine"
2014-11-01
|
| Series: | Medičnì Perspektivi |
| Subjects: | |
| Online Access: | http://medpers.dsma.dp.ua/issues/2014/N4/43-49.pdf |